• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大 COVID-19 大流行导致的预期寿命和生产力损失:对未来传染病控制政策的启示。

Losses of Life Expectancy and Productivity Associated with COVID-19 Pandemic in Canada: Policy Implication for Future Communicable Disease Control.

机构信息

Department of Economics, College of Social Science, National Cheng Kung University, Tainan 704, Taiwan.

Department of Public Health, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.

出版信息

Int J Environ Res Public Health. 2023 Jan 29;20(3):2419. doi: 10.3390/ijerph20032419.

DOI:10.3390/ijerph20032419
PMID:36767785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9916087/
Abstract

This research examines whether the Coronavirus disease 2019 (COVID-19) did harm to the population's health through comparing the changes in the life expectancy of Canadians with those of Australians over the period from March 2019 to February 2021 by using a difference-in-differences (DID) estimation method. We found that the pandemic did cause differences in life expectancies between Canada and Australia, probably because of different initial control policies for COVID-19. This study uses the indicator of disability-adjusted life years (DALYs) to measure the societal health burden, which was corroborated by estimating temporal productivity loss (TPL) and permanent productivity loss (PPL) based on the human capital approach (HCA) using data from Health Canada. The societal health burden in Canada amounted to 6.493 DALYs per 1000 male persons and 5.316 DALYs per 1000 female persons. The economy's permanent productivity loss was around USD 5.3 billion, while the temporary productivity loss was around USD 3 billion from February 2020 to April 2022. The sum of the above two losses amounted to 0.477% of the GDP in 2019. Swift and decisive decisions at the very early stage of a pandemic can nip contagions in the bud before numbers get out of hand and would be less damaging to people's health and the economy, as seen in Australia, in contrast to what happened in Canada. We thus recommend that such policies plus telecommunication systems in healthcare services be implemented early on to cope with the future outbreak of any emerging infectious diseases such as COVID-19.

摘要

本研究通过使用双重差分(DID)估计方法,比较了 2019 年 3 月至 2021 年 2 月期间加拿大和澳大利亚两国人口预期寿命的变化,以评估 2019 年冠状病毒病(COVID-19)是否对人群健康造成危害。我们发现,大流行确实导致了加拿大和澳大利亚之间预期寿命的差异,这可能是由于两国对 COVID-19 的初始控制政策不同。本研究使用伤残调整生命年(DALYs)来衡量社会健康负担,并通过使用加拿大卫生部的数据,根据人力资本方法(HCA)估计时间生产力损失(TPL)和永久生产力损失(PPL),对该指标进行了验证。加拿大的社会健康负担为每 1000 名男性 6.493 DALYs,每 1000 名女性 5.316 DALYs。经济的永久性生产力损失约为 53 亿美元,而从 2020 年 2 月到 2022 年 4 月的临时生产力损失约为 30 亿美元。上述两项损失之和占 2019 年 GDP 的 0.477%。在大流行的早期阶段迅速果断地做出决策,可以在疫情失控之前遏制疫情的蔓延,对人们的健康和经济造成的损害较小,这与加拿大形成鲜明对比。因此,我们建议在早期实施此类政策和医疗保健服务中的电信系统,以应对未来任何新发传染病(如 COVID-19)的爆发。

相似文献

1
Losses of Life Expectancy and Productivity Associated with COVID-19 Pandemic in Canada: Policy Implication for Future Communicable Disease Control.加拿大 COVID-19 大流行导致的预期寿命和生产力损失:对未来传染病控制政策的启示。
Int J Environ Res Public Health. 2023 Jan 29;20(3):2419. doi: 10.3390/ijerph20032419.
2
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.1990 - 2013年全球、区域和国家306种疾病和损伤的伤残调整生命年(DALYs)以及188个国家的健康预期寿命(HALE):量化流行病学转变
Lancet. 2015 Nov 28;386(10009):2145-91. doi: 10.1016/S0140-6736(15)61340-X. Epub 2015 Aug 28.
3
Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands.估算 COVID-19 大流行第一年中能力福利的损失:对英国、澳大利亚和荷兰一般成年人群体的横断面研究。
Eur J Health Econ. 2023 Jun;24(4):609-619. doi: 10.1007/s10198-022-01498-y. Epub 2022 Jul 24.
4
Estimation of the economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala, India: a model-based analysis.使用残疾调整生命年(DALYs)和印度喀拉拉邦生产力损失估算 COVID-19 的经济负担:基于模型的分析。
BMJ Open. 2021 Aug 18;11(8):e049619. doi: 10.1136/bmjopen-2021-049619.
5
Burden of COVID-19: DALY and productivity loss for Karnataka, India.COVID-19 负担:印度卡纳塔克邦的 DALY 和生产力损失。
Indian J Public Health. 2022 Jul-Sep;66(3):239-244. doi: 10.4103/ijph.ijph_959_21.
6
Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia.模拟澳大利亚维多利亚州新冠疫情政策对社会限制和封锁措施的反应与健康调整生命年和成本的关系。
JAMA Health Forum. 2021 Jul 30;2(7):e211749. doi: 10.1001/jamahealthforum.2021.1749. eCollection 2021 Jul.
7
Model-based estimation of burden of COVID-19 with disability-adjusted life years and value of statistical life in West Bengal, India.基于模型的印度西孟加拉邦 COVID-19 残疾调整生命年和统计生命价值负担估计。
BMJ Open. 2023 Jan 23;13(1):e065729. doi: 10.1136/bmjopen-2022-065729.
8
Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020.2020 年印度因 COVID-19 直接健康影响导致的伤残调整生命年(DALYs)。
Sci Rep. 2022 Feb 14;12(1):2454. doi: 10.1038/s41598-022-06505-z.
9
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家残疾调整生命年(DALYs)用于 333 种疾病和伤害以及 195 个国家和地区的健康期望寿命(HALE),1990-2016 年:全球疾病负担研究 2016 年的系统分析。
Lancet. 2017 Sep 16;390(10100):1260-1344. doi: 10.1016/S0140-6736(17)32130-X.
10
Estimating the Direct Disability-Adjusted Life Years Associated With SARS-CoV-2 (COVID-19) in the Republic of Ireland: The First Full Year.估算与 SARS-CoV-2(COVID-19)相关的直接伤残调整生命年在爱尔兰共和国的情况:第一年。
Int J Public Health. 2022 Jun 2;67:1604699. doi: 10.3389/ijph.2022.1604699. eCollection 2022.

引用本文的文献

1
The burden of COVID-19 based on disability-adjusted life years: a systematic review of available evidence.基于伤残调整生命年的新冠病毒病负担:现有证据的系统评价
Front Public Health. 2025 Feb 24;13:1401726. doi: 10.3389/fpubh.2025.1401726. eCollection 2025.

本文引用的文献

1
Life expectancy changes since COVID-19.自 COVID-19 以来,预期寿命发生了变化。
Nat Hum Behav. 2022 Dec;6(12):1649-1659. doi: 10.1038/s41562-022-01450-3. Epub 2022 Oct 17.
2
Scientific risk performance analysis and development of disaster management framework: A case study of developing Asian countries.科学风险绩效分析与灾害管理框架的发展:以亚洲发展中国家为例
J King Saud Univ Sci. 2021 Mar;33(2):101348. doi: 10.1016/j.jksus.2021.101348. Epub 2021 Jan 28.
3
A systematic literature review of disability weights measurement studies: evolution of methodological choices.残疾权重测量研究的系统文献综述:方法选择的演变
Arch Public Health. 2022 Mar 24;80(1):91. doi: 10.1186/s13690-022-00860-z.
4
Estimating US Earnings Loss Associated with COVID-19 Based on Human Capital Calculation.基于人力资本测算估算美国 COVID-19 相关的收入损失。
Int J Environ Res Public Health. 2022 Jan 17;19(2):1015. doi: 10.3390/ijerph19021015.
5
A disproportionate epidemic: COVID-19 cases and deaths among essential workers in Toronto, Canada.不成比例的疫情:加拿大多伦多的基本工人中的 COVID-19 病例和死亡。
Ann Epidemiol. 2021 Nov;63:63-67. doi: 10.1016/j.annepidem.2021.07.010. Epub 2021 Jul 24.
6
Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations.2020 年美国因 COVID-19 导致的预期寿命下降,以及对黑人和拉丁裔人口的不成比例影响。
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5). doi: 10.1073/pnas.2014746118.
7
Fear, lockdown, and diversion: Comparing drivers of pandemic economic decline 2020.恐惧、封锁与转移:2020年大流行经济衰退驱动因素比较
J Public Econ. 2021 Jan;193:104311. doi: 10.1016/j.jpubeco.2020.104311. Epub 2020 Nov 25.
8
Explaining among-country variation in COVID-19 case fatality rate.解释 COVID-19 病死率的国家间差异。
Sci Rep. 2020 Nov 3;10(1):18909. doi: 10.1038/s41598-020-75848-2.
9
An overview of the pathogenic mechanisms involved in severe cases of COVID-19 infection, and the proposal of salicyl-carnosine as a potential drug for its treatment.新冠病毒感染重症病例的发病机制概述,以及水杨酰-肌肽作为其治疗潜在药物的提出。
Eur J Pharmacol. 2020 Nov 5;886:173457. doi: 10.1016/j.ejphar.2020.173457. Epub 2020 Aug 1.
10
Impact of the Burden of COVID-19 in Italy: Results of Disability-Adjusted Life Years (DALYs) and Productivity Loss.意大利 COVID-19 负担的影响:残疾调整生命年 (DALYs) 和生产力损失的结果。
Int J Environ Res Public Health. 2020 Jun 13;17(12):4233. doi: 10.3390/ijerph17124233.